date |
content |
Aug. 2017 |
Listing in the Canada Stock Exchange (CSE) |
Oct. 2016 |
Started Production of hair production containing 5 kinds of growth factors |
Oct. 2016 |
Bio-similar and a FMD Vaccine joint factory project with ORNA, Turkey |
Oct. 2016 |
Contracted joint venture for FMD Vaccine production with Pharos Vaccine, Korea |
Aug. 2016 |
Established Biopharma-Switzerland in Zurich, Switzerland (main shareholder) |
Jul. 2016 |
Final discussing a Bio-similar joint factory project with Royan Group, Iran |
Sep. 2015 |
Completed capital increase with consideration (issued total 3,158,887 shares) |
Jan. 2015 |
Agreed with Biocurepharm-Atabay(Turkey) for joint development of Ranibizumab |
Aug. 2012 |
Attracted FDI USD500Mil from Macauley Gehler, Singapore |
Jan. 2012 |
Established Biocurepharm-MG in Singapore with Macauley Gehler |
Mar. 2011 |
Completed joint development of a detection kit of breast cancer (clinical test started) |
Dec. 2007 |
Achieved export of USD 4.5 million |
Nov. 2006 |
Awarded the national export tower of USD 1 million |
Aug. 2005 |
Company founded (Paid-in capital of USD 50,000) |